Lung Cancer Patient Story: Multidisciplinary Expertise Backed by Cutting-edge Treatment
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General.
Contact Information
Support Lung Cancer Research
Your gift will help our team advance research into new, targeted therapies to improve outcomes for patients with lung cancer. Make a gift.
The Center for Thoracic Cancers provides individualized, compassionate care and the most advanced treatments for patients with thoracic cancers, including:
The Center for Thoracic Cancers offers a collaborative, caring approach to the diagnosis and treatment of our patients. Consistently ranked as one of the best in the country by U.S. News & World Report, we provide the latest, most effective treatments including many innovative approaches to clinical care and promising new therapies.
Our team approach ensures that every patient benefits from a personalized, coordinated and compassionate treatment plan that includes leading experts across many specialties. Depending on the stage and other characteristics of your cancer, this treatment plan may include surgery, chemotherapy, radiation, or a combination of these therapies.
We work collaboratively with surgeons in Massachusetts General Hospital's Division of Thoracic Surgery, who specialize in complex surgical techniques to treat patients with thoracic cancers.
Members of your care team meet regularly with you and contact your referring physician on an ongoing basis to ensure clear communication and a seamless coordination of care.
Learn about our Lung Cancer Treatment Program.
Search the Cancer Center's open clinical trials.
A checklist of items to bring with you for your first visit and helpful information.
We offer a variety of education and support resources to help you and your family.
Mass General has the only proton therapy site in all of New England, with two proton therapy centers.
This helped lead to new knowledge and breakthrough therapies.
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General.
Targeted therapy and world-class care at Mass General Cancer Center has given Ann Malik a new lease on life and a passion for inspiring others. Read more about her journey with ROS1-positive lung cancer.
Using information from a single low-dose chest computed tomography scan, ‘Sybil’ accurately predicted individuals’ lung cancer risk for one to six years in the future, pointing a way toward personalized screening.
Contact us to make an appointment or to learn more about our programs.